Comparative efficacy of intralesional Cryotherapy vs intralesional Corticosteroi 5 Fluorouracil in the treatment of hypertrophic scars and keloids
Phase 2
Recruiting
- Conditions
- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere.Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
- Registration Number
- IRCT20100314003566N9
- Lead Sponsor
- Vice chancellor for Research,Tabriz University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 63
Inclusion Criteria
Patients withof hypertrophic scars and keloids
Age 12 and older
Exclusion Criteria
Pregnant
Breastfeeding women
Age less than 12 years
history of allergy to the drugs used in the research
liver and kidney disease
Immune system deficiency
Reduction in blood cell levels
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Scar Volume. Timepoint: Every 4 weeks, depending on the scar tissue, up to 6 sessions. Method of measurement: Using the vernier scale tool.
- Secondary Outcome Measures
Name Time Method Complications of treatment. Timepoint: Monthly, up to 6 months. Method of measurement: Clinical observation.